RA Capital Management - EIDOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
RA Capital Management ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$109,310,000
+6.0%
2,163,271
+0.0%
2.00%
-0.5%
Q2 2020$103,095,000
-2.7%
2,162,6710.0%2.01%
-40.0%
Q1 2020$105,949,000
-14.6%
2,162,6710.0%3.35%
-11.1%
Q4 2019$124,116,000
+59.6%
2,162,6710.0%3.76%
-18.8%
Q3 2019$77,791,000
-31.0%
2,162,6710.0%4.64%
-23.4%
Q2 2019$112,726,000
+23.8%
2,162,6710.0%6.05%
+54.1%
Q1 2019$91,070,000
+53.8%
2,162,6710.0%3.93%
+14.0%
Q4 2018$59,206,000
+174.3%
2,162,6710.0%3.45%
+198.6%
Q3 2018$21,583,000
-50.9%
2,162,6710.0%1.15%
-59.6%
Q2 2018$43,989,0002,162,6712.86%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders